Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-R Yun

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Obesity (2005)|September 13, 2017
Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db miceG Kim, Y-H Lee, M R Yun, et al.
Oncogene|September 26, 2017
ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinomaM R Yun, H M Choi, H N Kang, et al.
International Journal of Obesity (2005)|August 29, 2015
Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPKY-H Lee, M R Yun, H M Kim, et al.
Oncogenesis|July 19, 2016
Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapyS-M Kim, H Kim, M R Yun, et al.
Physical Review Letters|February 18, 2022
Experimental Verification of Dissipation-Time Uncertainty RelationL-L Yan, J-W Zhang, M-R Yun, et al.
Oncogene|January 17, 2017
Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibitionH S Kim, M Jung, H N Kang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinomaH R Kim, H N Kang, H S Shim, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Obesity (2005)|September 13, 2017
Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db miceG Kim, Y-H Lee, M R Yun, et al.
Oncogene|September 26, 2017
ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinomaM R Yun, H M Choi, H N Kang, et al.
International Journal of Obesity (2005)|August 29, 2015
Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPKY-H Lee, M R Yun, H M Kim, et al.
Oncogenesis|July 19, 2016
Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapyS-M Kim, H Kim, M R Yun, et al.
Physical Review Letters|February 18, 2022
Experimental Verification of Dissipation-Time Uncertainty RelationL-L Yan, J-W Zhang, M-R Yun, et al.
Oncogene|January 17, 2017
Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibitionH S Kim, M Jung, H N Kang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinomaH R Kim, H N Kang, H S Shim, et al.
Pageof 1